(LOGC) Logicbio Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Logicbio Therapeutics | (LOGC) share price targets
Complete technical analysis of Logicbio Therapeutics (LOGC) by charts plus indicators, forecast predictions and share price targets for Logicbio Therapeutics (LOGC)
Logicbio Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-07-31 View latest technical analysis
10 day averaged volume of Logicbio Therapeutics is 214641
Date | Daily Closing Price | Open | High | Low | Volume |
31 Wed Jul 2024 | 5.40 | 5.70 | 5.78 | 5.34 | 4.918 times |
30 Tue Jul 2024 | 5.69 | 5.75 | 5.83 | 5.67 | 0.69 times |
29 Mon Jul 2024 | 5.78 | 5.74 | 5.84 | 5.71 | 0.59 times |
26 Fri Jul 2024 | 5.79 | 5.77 | 5.85 | 5.71 | 0.561 times |
25 Thu Jul 2024 | 5.71 | 5.71 | 5.85 | 5.68 | 0.565 times |
24 Wed Jul 2024 | 5.74 | 5.82 | 5.85 | 5.69 | 1.018 times |
23 Tue Jul 2024 | 5.85 | 5.80 | 5.87 | 5.80 | 1.825 times |
22 Mon Jul 2024 | 5.85 | 6.05 | 6.07 | 5.79 | 1.092 times |
19 Fri Jul 2024 | 6.00 | 5.98 | 6.18 | 5.93 | 1.627 times |
18 Thu Jul 2024 | 6.03 | 6.10 | 6.23 | 6.00 | 0.992 times |
Stock of Logicbio Therapeutics (LOGC) has showed a significant fall. This could be a good time to exit from this stock.
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 5.4, for a target of 5.7 or 5.84
Share price targets for Logicbio Therapeutics (LOGC)
Target Type | Value |
Downside Target | 2.00 |
Downside Target | 2.05 |
Downside Target | 5.00 |
Downside Target | 5.31 |
Upside Target | 5.55 |
Upside Target | 5.84 |
Upside Target | 5.85 |
Upside Target | 5.93 |
Upside Target | 6.05 |
Upside Target | 6.07 |
Upside Target | 6.29 |
Intraday share price targets for Logicbio Therapeutics (LOGC)
Target Type | Value |
Downside Intraday Target | 5.21 |
Downside Intraday Target | 5.03 |
Upside Intraday Target | 5.71 |
Upside Intraday Target | 6.03 |
Upside Intraday Target | 5.53 |
Weekly technical analysis of Logicbio Therapeutics (LOGC)
Date | Weekly Closing Price | Open | High | Low | Volume |
31 Wed Jul 2024 | 5.40 | 5.74 | 5.84 | 5.34 | 1.225 times |
26 Fri Jul 2024 | 5.79 | 6.05 | 6.07 | 5.68 | 0.768 times |
19 Fri Jul 2024 | 6.00 | 6.04 | 6.29 | 5.93 | 1.579 times |
12 Fri Jul 2024 | 6.01 | 5.75 | 6.07 | 5.55 | 2.544 times |
05 Fri Jul 2024 | 5.78 | 5.61 | 5.85 | 5.57 | 0.301 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Logicbio Therapeutics (LOGC)
Date | Monthly Closing Price | Open | High | Low | Volume |
31 Wed Jul 2024 | 5.40 | 5.59 | 6.29 | 5.34 | 0.604 times |
28 Fri Jun 2024 | 5.71 | 5.38 | 6.05 | 5.31 | 1.706 times |
31 Fri May 2024 | 5.46 | 5.00 | 5.85 | 5.00 | 2.655 times |
15 Tue Nov 2022 | 2.07 | 2.05 | 2.07 | 2.05 | 0.088 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Logicbio Therapeutics (LOGC)
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Logicbio Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Logicbio Therapeutics in short term but the sell signal is initial and weak.
Logicbio Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Logicbio Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Logicbio Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.69 and Logicbio Therapeutics (LOGC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Logicbio Therapeutics (LOGC) stock. Volume based technical analysis of Logicbio Therapeutics (LOGC) stock is negative.
Logicbio Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Logicbio Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Logicbio Therapeutics in short term but the sell signal is initial and weak.
Logicbio Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Logicbio Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Logicbio Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.69 and Logicbio Therapeutics (LOGC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Logicbio Therapeutics (LOGC) stock. Volume based technical analysis of Logicbio Therapeutics (LOGC) stock is negative.
Logicbio Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.